🇺🇸 FDA
Patent

US 7968298

Use of herpesviruses, herpesvirus proteins and nucleic acids encoding the proteins to inhibit CCR5-tropic HIV-1 infection and replication

granted A61KA61K35/763A61K38/162

Quick answer

US patent 7968298 (Use of herpesviruses, herpesvirus proteins and nucleic acids encoding the proteins to inhibit CCR5-tropic HIV-1 infection and replication) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K35/763, A61K38/162, A61K48/00, A61P